FIELD: biochemistry.
SUBSTANCE: present invention relates to a method for producing a herpes virus, including culturing a cell infected with said herpes virus, in a cell culture that contains aurintricarboxylic acid and fetal calf serum. Invention also relates to a method for culturing a cell and to the use of aurintricarboxylic acid.
EFFECT: inventions allow the use of an iNOS inhibitor, aurintricarboxylic acid, to increase the yield of the herpes virus in the cell culture and can be used in the medical industry.
10 cl, 11 dwg, 3 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF iNOS INHIBITORS TO INCREASE VIRUS YIELD IN CULTURE | 2014 |
|
RU2795456C2 |
| RNAi AGENT OPTION | 2018 |
|
RU2789647C2 |
| GENE EDITING OF DEEP INTRON MUTATIONS | 2016 |
|
RU2759335C2 |
| LINES OF ENGINEERED PRODUCER CELLS AND METHODS FOR PRODUCTION AND USE THEREOF | 2020 |
|
RU2823068C2 |
| AVV VECTORS WITH IMPROVED Rep-CODING SEQUENCES USED IN INSECT CELL PRODUCTION SYSTEMS | 2007 |
|
RU2457252C2 |
| PRODUCTION OF AAV IN INSECT CELLS, METHODS AND COMPOSITIONS FOR THIS PURPOSE | 2017 |
|
RU2739596C2 |
| COMPOSITIONS AND METHODS OF TREATING AND PREVENTING MACULAR DEGENERATION | 2015 |
|
RU2703145C2 |
| GENE THERAPY FOR NEURODEGENERATIVE DISORDERS | 2010 |
|
RU2603740C2 |
| GENE THERAPY OF NEURODEGENERATIVE DISORDERS | 2010 |
|
RU2743398C2 |
| MODIFIED CAPSID PROTEINS FOR IMPROVED DELIVERY OF PARVOVIRUS VECTORS | 2016 |
|
RU2751953C2 |
